H. Süli‐Vargha

发表

ANTAGONIST AND AGONIST ACTIVITIES OF THE MOUSE AGOUTI PROTEIN FRAGMENT (91–131) AT THE MELANOCORTIN-1 RECEPTOR

A. Eberle, U. Zumsteg, V. Jäggin, 2001, Journal of receptor and signal transduction research.

Peptides and pseudopeptides incorporating D‐Phe–Pro–Arg and Arg–Gly–Asp lead sequences as potential antithrombotic agents

J. Ilaš, F. Hudecz, D. Kikelj, 2008, Journal of peptide science : an official publication of the European Peptide Society.

The synthesis of alternative diketopiperazines as potential RGD mimetics

R. Kiss, J. Ilaš, A. Csámpai, 2006, Journal of peptide science : an official publication of the European Peptide Society.

Locally generated VGVAPG and VAPG elastin‐derived peptides amplify melanoma invasion via the galectin‐3 receptor

A. Falus, Péter Pócza, H. Süli‐Vargha, 2007, International journal of cancer.

The antiproliferative action of a melphalan hexapeptide with collagenase-cleavable site

J. Botyánszki, J. Oláh, A. Jeney, 1998, Cancer Chemotherapy and Pharmacology.

Synthesis of peptides containing bis-imidazole ligands

H. Süli‐Vargha, Z. Likó, 1993 .

Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1,d-Ala2, Leu5-enkephalin binding

J. Szécsi, A. Borsodi, G. Tóth, 1985, Neurochemical Research.

Comparative conformational studies on cyclic hexapeptides corresponding to message sequence His-Phe-Arg-Trp of alpha-melanotropin by NMR.

E. Coutinho, A. Saran, M. M. Dhingra, 2009, The journal of peptide research : official journal of the American Peptide Society.

BCNU is a caspase-mediated inhibitor of drug-induced apoptosis.

P. Bauer, I. Peták, R. Mihalik, 1998, Cancer research.

1,4‐Diazepine‐2,5‐dione ring formation during solid phase synthesis of peptides containing aspartic acid β‐benzyl ester

J. Ilaš, Gitta Schlosser, H. Süli‐Vargha, 2007, Journal of peptide science : an official publication of the European Peptide Society.

Potentiometric and spectroscopic studies on the copper(II) and zinc(II) complexes of bis(imidazol-2-yl) derivatives of tripeptides

G. Micera, D. Sanna, I. Sóvágó, 2006 .

Copper(II) complexes of amino acid derivatives of the bis(imidazol-2-yl)methyl residue

A. Csámpai, G. Micera, D. Sanna, 2004 .

Acid-base properties and copper(II) complexes of dipeptides containing histidine and additional chelating bis(imidazol-2-yl) residues.

G. Micera, D. Sanna, I. Sóvágó, 2004, Journal of inorganic biochemistry.

Transition metal complexes of bis(imidazol-2-yl) derivatives of dipeptides

G. Micera, D. Sanna, I. Sóvágó, 2003 .

Copper(II), nickel(II) and zinc(II) complexes of amino acids containing bis(imidazol-2-yl)methyl residues

G. Micera, D. Sanna, I. Sóvágó, 2002 .

Potentiometric and spectroscopic studies on copper(II) and zinc(II) complexes of peptides containing bis(imidazolyl) ligands

G. Micera, D. Sanna, I. Sóvágó, 1994 .

Equilibrium and structural studies on transition metal complexes of amino acid derivatives containing the bis(pyridin-2-yl)methyl residue

G. Micera, D. Sanna, I. Sóvágó, 2001 .

The effect of histidyl residues on the complexation of bis(imidazolyl) containing tripeptides with copper(II) ion.

G. Micera, I. Sóvágó, K. Várnagy, 2000, Journal of inorganic biochemistry.

Potentiometric and spectroscopic studies of transition metal complexes of bis(imidazolyl) and bis(pyridyl) derivatives of amino acids

G. Micera, D. Sanna, I. Sóvágó, 1998 .

Copper(II) and Zinc(II) Complexes of Peptides as Models for Collagenase Inhibitors

K. Várnagy, H. Süli‐Vargha, 1997 .

Synthesis and in vitro examination of type-IV collagenase

J. Botyánszki, H. Süli‐Vargha, Z. Likó, 1995 .

Receptor-mediated cytotoxicity of alpha-MSH fragments containing melphalan in a human melanoma cell line.

G. Ghanem, R. Morandini, J. Botyánszki, 1994, International journal of cancer.

Synthesis of α-MSH fragments containing phenylalanine mustard for receptor studies

J. Botyánszki, H. Süli‐Vargha, H. Medzihradszky-Schweiger, 2009 .

Activity and conformation of a cyclic heptapeptide possessing the message sequence His-Phe-Arg-Trp of alpha-melanotropin.

E. Coutinho, P. Desai, A. Saran, 2002, International journal of biological macromolecules.

The effect of N-terminal substitutions on the biological activity of MSH fragments

H. Süli‐Vargha, H. Medzihradszky-Schweiger, K. Medzihradszky, 1992, Peptides.

Effects of α-melanotropin C-terminal tripeptide analogues on macrophage NO production

J. Wikberg, R. Muceniece, H. Süli‐Vargha, 2003, Peptides.

New strategy for the synthesis of large peptides as applied to the C-terminal cysteine-rich 41 amino acid fragment of the mouse agouti protein

K. Vékey, K. Ludányi, G. Orosz, 1997 .

Cell‐physiological effects of elastin derived (VGVAPG)n oligomers in a unicellular model system

G. Csaba, L. Köhidai, Z. Majer, 2004, Journal of peptide science : an official publication of the European Peptide Society.

Synthesis of the C‐terminal domain of the tissue inhibitor of metalloproteinases‐1(TIMP‐1)

K. Medzihradszky, A. Hajnal, H. Süli‐Vargha, 2003, Journal of Peptide Science.

Synthesis and biological activity of cyclic melanotropin peptides

H. Süli‐Vargha, H. Medzihradszky-Schweiger, J. Bódi, 1991 .

Synthesis, biological activity and conformational investigations of novel cyclic melanotropin fragment analogs

L. Radics, H. Süli‐Vargha, H. Medzihradszky-Schweiger, 1995 .

An alternative solid phase peptide fragment condensation protocol with improved efficiency

Á. Gömöry, H. Süli‐Vargha, N. Mihala, 2001, Journal of Peptide Science.

Structural determinants of the binding of gliadin fragments to human peripheral blood lymphocytes

G. Fasman, L. Gráf, M. Hollósi, 1990, Neuropeptides.